NIH #5R01NS117666-04
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Expiring Soon
- Amount
- $430K
- Period
- 2021-09-15 → 2026-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5R01NS117666-03
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Expiring Soon
- Amount
- $471K
- Period
- 2021-09-15 → 2026-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5R01NS117666-02
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Expiring Soon
- Amount
- $443K
- Period
- 2021-09-15 → 2026-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #1R01NS117666-01
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Expiring Soon
- Amount
- $443K
- Period
- 2021-09-15 → 2026-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #1R01NS144449-01
Targeting MBD2 for medulloblastoma therapy
Active
- Amount
- $564K
- Period
- 2025-09-09 → 2030-08-31
- PIs
- 1
- Est. capacity / PI
- ~7 students
NIH #5R01NS117666-05
Mechanisms underlying BAI1/ADGRB1 negative regulation of glioblastoma mesenchymal transition and invasion.
Active
- Amount
- $98K
- Period
- 2021-09-15 → 2027-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5P30CA013148-53
Shared Resource Management
Active
- Amount
- $485K
- Period
- 1997-03-28 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5P30CA013148-52
Shared Resource Management
Active
- Amount
- $458K
- Period
- 1997-03-28 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5P30CA013148-51
Shared Resource Management
Active
- Amount
- $2.8M
- Period
- 1997-03-28 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
NIH #5P30CA013148-50
Shared Resource Management
Active
- Amount
- $2.8M
- Period
- 1997-03-28 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
NIH #2P30CA013148-49
Shared Resource Management
Active
- Amount
- $2.8M
- Period
- 1997-03-28 → 2027-03-31
- PIs
- 1
- Est. capacity / PI
- ~1 students
NIH #3R01CA235162-06S1
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $63K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5R01CA235162-06
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $404K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #3R01CA235162-05S1
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $65K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5R01CA235162-05
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $417K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #3R01CA235162-04S1
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $26K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5R01CA235162-04
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $417K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5R01CA235162-03
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $425K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #7R01CA235162-02
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $425K
- Period
- 2019-09-01 → 2025-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #7R01NS096236-05
Targeting Mechanisms of Medulloblastoma Formation
- Amount
- $368K
- Period
- 2020-07-01 → 2023-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
NIH #5P30CA138292-13
Cancer Cell Biology
- Amount
- $83K
- Period
- 2009-04-07 → 2023-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01NS096236-03
Targeting mechanisms of medulloblastoma formation
- Amount
- $386K
- Period
- 2016-07-01 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01NS096236-02
Targeting mechanisms of medulloblastoma formation
- Amount
- $386K
- Period
- 2016-07-01 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #1R01NS096236-01
Targeting mechanisms of medulloblastoma formation
- Amount
- $386K
- Period
- 2016-07-01 → 2021-06-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01NS096236-04
Targeting mechanisms of medulloblastoma formation
- Amount
- $386K
- Period
- 2016-07-01 → 2020-02-01
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA176001-05
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
- Amount
- $324K
- Period
- 2013-12-15 → 2019-11-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #1R01CA235162-01A1
Evaluating ADGRB3 as a tumor suppressor epigenetically silenced in WNT medulloblastoma
- Amount
- $21K
- Period
- 2019-09-01 → 2019-09-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA176001-04
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
- Amount
- $324K
- Period
- 2013-12-15 → 2018-11-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA176001-03
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
- Amount
- $324K
- Period
- 2013-12-15 → 2018-11-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3R01CA176001-03S1
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
- Amount
- $48K
- Period
- 2013-12-15 → 2018-11-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA176001-02
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
- Amount
- $324K
- Period
- 2013-12-15 → 2018-11-30
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA163722-05
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $324K
- Period
- 2013-04-01 → 2018-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3R01CA163722-05S1
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $11K
- Period
- 2013-04-01 → 2018-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3R01CA163722-04S1
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $7K
- Period
- 2013-04-01 → 2018-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #4R01CA163722-04
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $324K
- Period
- 2013-04-01 → 2018-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3R01CA163722-04S2
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $51K
- Period
- 2013-04-01 → 2018-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #4P30CA138292-08
CANCER CELL BIOLOGY
- Amount
- $34K
- Period
- — → 2017-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3R01CA163722-03S1
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $49K
- Period
- 2013-04-01 → 2016-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5R01CA163722-03
Defining mechanisms of extracellular communication for cancer therapy
- Amount
- $324K
- Period
- 2013-04-01 → 2016-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5P30CA138292-07
CANCER CELL BIOLOGY
- Amount
- $34K
- Period
- — → 2016-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #5P30CA138292-12
Cancer Cell Biology
- Amount
- $83K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at EMORY UNIVERSITY
NIH #3P30CA138292-12S2
Cancer Cell Biology
- Amount
- $60K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3P30CA138292-12S1
Cancer Cell Biology
- Amount
- $50K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3P30CA138292-11S3
Cancer Cell Biology
- Amount
- $500K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~8 students
Awarded at EMORY UNIVERSITY
NIH #5P30CA138292-11
Cancer Cell Biology
- Amount
- $83K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at EMORY UNIVERSITY
NIH #3P30CA138292-10S1
Cancer Cell Biology
- Amount
- $5K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3P30CA138292-10S2
Cancer Cell Biology
- Amount
- $13K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY
NIH #3P30CA138292-10S3
Cancer Cell Biology
- Amount
- $234K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~3 students
Awarded at EMORY UNIVERSITY
NIH #5P30CA138292-10
Cancer Cell Biology
- Amount
- $83K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~1 students
Awarded at EMORY UNIVERSITY
NIH #2P30CA138292-09
Cancer Cell Biology
- Amount
- $50K
- Period
- — → —
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at EMORY UNIVERSITY